CIK In Vivo Test Services

Online Inquiry

CIK therapy, as a novel immunotherapy strategy, shows remarkable promise. Creative Biolabs offers CIK in vivo test services to provide a wide variety of support tailored to your needs. We can customize the optimal design for animal models, allowing for accurate evaluation of the anti-tumor activity of CIK cells in vivo. Additionally, using high-throughput analysis techniques, we can precisely identify the various subpopulations of CIK immune cells and the phenotypes of tumor-infiltrating lymphocytes (TILs).

Introduction

In the fast-paced landscape of tumor immunotherapy, CIK cell therapy has become a significant area of interest. To meet this growing need, Creative Biolabs has created an extensive suite of CIK in vivo test services aimed at offering strong assistance for the research and development of CIK cell therapies. Through our expert and precise analytical services, we assist clients in achieving more profound research outcomes in the field of CIK in vivo testing. Whether it's designing animal models, conducting anti-tumor assays, analyzing CIK immune cell subtypes, or identifying TIL phenotypes, we are committed to providing top-quality service to our clients, working together to advance the progress of CIK cell therapy.

Generation and Clinical Application of CIK Cells. Fig.1 CIK Cell Therapy.¹

Services

Recently, CIK therapy has emerged as a promising approach for cancer treatment. As a leading preclinical CRO bio-company, Creative Biolabs offers a full range of CIK in vivo Test services to clients worldwide.

CIK Animal Model Design and Management Services

Creative Biolabs recognizes that each tumor research project requires the appropriate animal model to ensure the validity of the results. Our team of experts is well-equipped to create customized CIK animal models to meet the specific needs of each project, ensuring biological relevance. Through meticulous management and monitoring, we maintain the quality of the animal models to guarantee reliable experimental outcomes. Whether your research entails mice, rats, or other species, we provide the most suitable options.

CIK In Vivo Antitumor Activity Testing Services

Assessing the antitumor activity of CIK cells is a pivotal aspect of our offerings. Our CIK in vivo antitumor activity testing focuses on measuring and evaluating the effects of CIK cells against various tumor models. With systematic experimental designs and precise data analysis, we assist clients in understanding the inhibitory effects of CIK cells on tumor growth in vivo, thereby providing a solid scientific foundation for subsequent clinical studies.

CIK Immune Cell Subpopulation Analysis Services

Understanding the composition and function of CIK cell subpopulations is essential for optimizing immunotherapy. Our labs provide advanced cell sorting techniques and flow cytometry to conduct detailed subpopulation analyses of CIK cells. By examining the ratios and functions of different subpopulations, we provide detailed immunological insights that help clients comprehend the role of CIK cells within the tumor microenvironment.

Tumor-infiltrating Lymphocyte Phenotype Identification Services

The identification of tumor-infiltrating lymphocyte (TIL) phenotypes is a key step in evaluating the effectiveness of CIK cell therapy. Our TIL phenotype identification service uses advanced molecular biology techniques to conduct precise phenotypic analyses of TILs. Our service enables clients to gain deeper insights into the distribution and functional characteristics of immune cells within the tumor microenvironment, illuminating the mechanisms by which CIK cells contribute to tumor immune responses. The data we provide will offer substantial support for the optimization of CIK therapy strategies and the development of personalized therapy protocols.

Cytotoxicity of CRLM Donor-derived CIK Cells. Fig.2 A Cytotoxicity Analysis Assay of CIK Cells.²

Why Choose Us

Real-Time Detection System: Our testing services offer real-time evaluations of the activity and functionality of immune cells in the body, providing clients with many ideas for timely adjustments to CIK therapy plans.
High Sensitivity and Specificity: Utilizing advanced testing technologies, our team ensures a highly sensitive and specific assessment of CIK cell activity and its behavior within the tumor microenvironment, thereby enhancing the reliability of the results.
Enhanced Efficacy Prediction: Through in vivo testing, Creative Biolabs can effectively predict antitumor responses to CIK therapy, providing a scientific foundation for subsequent treatments and helping to achieve better therapeutic outcomes.
Diverse Testing Options: Our services include a wide range of testing options, such as cellular proliferation, cytotoxicity, and immune memory assessments, tailored to meet the varying needs of our clients.
Expert Team Support: Backed by a skilled and experienced team, we offer comprehensive technical support and consulting services, ensuring a smooth testing process and accurate interpretation of results.

Our services are distinguished by unique technological advantages, including high-throughput testing, high-sensitivity analysis, and precise data interpretation, all designed to significantly enhance your research efficiency and the quality of your results. Creative Biolabs ensures that experiments progress with the highest standards while also providing tailored consulting and support for each client. If you are interested in our CIK in vivo test services or have additional needs and inquiries, please do not hesitate to contact us.

References

Jäkel, Clara E., et al. "Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma." Journal of Immunology Research 2012.1 (2012): 473245. Distributed under Open Access license CC BY 3.0, without modification.
Li, Celine Man Ying, et al. "Generation and assessment of cytokine-induced killer cells for the treatment of colorectal cancer liver metastases." Cancer Immunology, Immunotherapy 73.1 (2024): 6. Distributed under Open Access license CC BY 4.0, without modification.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.